Luxemburg, 28/02/2006 (Agence Europe) - At the EU Court of First Instance, the Artegodan company from Lüchow in Germany is seeking damages of almost 1.5 million euro from the European Commission following the removal from the market, which the European Court of Justice found illegal, of its anti-obesity medicine, Tenuate retard. The German firm also wants the Commission to be required to compensate it for all future damages which it will incur as a result of marketing expenses which are...